KLAR — Klaria Pharma Holding AB (publ) Balance Sheet
0.000.00%
- SEK125.45m
- SEK123.53m
- SEK2.25m
Annual balance sheet for Klaria Pharma Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 31.3 | 25.5 | 16.8 | 1.25 | 0.598 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.38 | 1.76 | 23.5 | 1.89 | 1.27 |
| Prepaid Expenses | |||||
| Total Current Assets | 33 | 27.8 | 40.8 | 4.47 | 2.85 |
| Net Property, Plant And Equipment | 0.281 | 1.72 | 1.07 | 0.372 | 1.47 |
| Net Intangible Assets | |||||
| Total Assets | 132 | 118 | 120 | 72.9 | 57.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.8 | 47.9 | 43.8 | 31.8 | 53.3 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 22.8 | 48.9 | 44.2 | 31.8 | 54 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 110 | 69.4 | 76.1 | 41.1 | 3.3 |
| Total Liabilities & Shareholders' Equity | 132 | 118 | 120 | 72.9 | 57.3 |
| Total Common Shares Outstanding |